A recent story by NPR echoes the findings of a collaboration between DrugPatentWatch and Bloomberg, which examined increasing competition between […]

Developing a new drug is an arduous, often decade-long odyssey, demanding an average investment of $2.6 billion. The journey is

In an industry where the stakes are measured in billions and the outcomes in human lives, how does a pharmaceutical

Understanding the Pharmaceutical Patent Landscape For decades, patent protection has served as the bedrock of pharmaceutical innovation, providing companies with

How Rucaparib Patents Illustrate IP Value Creation in Biopharma The biopharmaceutical industry, a crucible of scientific innovation, operates on a

I. Executive Summary This report chronicles the remarkable 20-year evolution of in silico ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity)

DrugPatentWatch has published a list of research papers citing DrugPatentWatch at https://www.drugpatentwatch.com/citations/ Explore the Growing Body of Research Citing DrugPatentWatch

The Unsung Heroes of Healthcare: Understanding Generic Drug Utilization Generic drugs represent a remarkable achievement in pharmaceutical science and public

The pharmaceutical and biotechnology industries stand at a pivotal juncture, facing a confluence of challenges that threaten traditional research and